ASNB Financials 07/16/2014 17:48:33 AdvanSource B
Post# of 20
Posted On: 07/16/2014 6:48:29 PM
ASNB Financials 07/16/2014 17:48:33
AdvanSource Biomaterials Corp.
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 2,195 1,866 1,666 2,117
Cost of Revenue 813 897 1,523 1,356
Gross Profit 1,382 969 143 761
Operating Expenses
Research and Development 444 605 734 657
Sales, General and Admin. 1,609 1,844 2,491 2,727
Non-Recurring Items - 16 103 -
Other - - - -
Operating Income (671) (1,496) (3,185) (2,623)
Income From Continuing Operations
Add'l Income/Expense Items - (151) - (7)
Earnings Before Interest and Tax (671) (1,496) (3,185) (2,630)
Interest Expense 340 165 - -
Earnings Before Tax (1,011) (1,661) (3,185) (2,630)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,011) (1,812) (3,185) (2,630)
Non Recurring Events
Discontinued Operations - - - 942
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,011) (1,812) (3,185) (1,688)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,011) (1,812) (3,185) (1,688)
AdvanSource Biomaterials Corp.
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue 2,195 1,866 1,666 2,117
Cost of Revenue 813 897 1,523 1,356
Gross Profit 1,382 969 143 761
Operating Expenses
Research and Development 444 605 734 657
Sales, General and Admin. 1,609 1,844 2,491 2,727
Non-Recurring Items - 16 103 -
Other - - - -
Operating Income (671) (1,496) (3,185) (2,623)
Income From Continuing Operations
Add'l Income/Expense Items - (151) - (7)
Earnings Before Interest and Tax (671) (1,496) (3,185) (2,630)
Interest Expense 340 165 - -
Earnings Before Tax (1,011) (1,661) (3,185) (2,630)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,011) (1,812) (3,185) (2,630)
Non Recurring Events
Discontinued Operations - - - 942
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,011) (1,812) (3,185) (1,688)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,011) (1,812) (3,185) (1,688)
(0)
(0)